Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen to acquire Synergen for $239.6 million

Executive Summary

Amgen agreed to acquire Synergen for $239.6 million, paying $9.25 per share for Synergen's 25.9 million outstanding shares. An additional 2 million option shares may be acquired, raising the cost of the buyout to $258 million.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register